Skip to main content
Signal8

PR Newswire press releases

Full-text press releases distributed by PR Newswire, newest first. Times are US Eastern.

Source: PR Newswire

  1. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of VinFast Auto Ltd. - VFS

    $VFS

    Pomerantz LLP is investigating claims on behalf of investors of VinFast Auto Ltd. ("VinFast" or the "Company") (NASDAQ: VFS).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

  2. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ethos Technologies Inc. - LIFE

    $LIFE

    Pomerantz LLP is investigating claims on behalf of investors of Ethos Technologies Inc. ("Ethos" or the "Company") (NASDAQ: LIFE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

  3. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of State Street Corporation - STT

    $STT

    Pomerantz LLP is investigating claims on behalf of investors of State Street Corporation ("State Street" or the "Company") (NYSE: STT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

  4. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ

    $JNJ

    Pomerantz LLP is investigating claims on behalf of investors of Johnson & Johnson ("J&J" or the "Company") (NYSE: JNJ). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

  5. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amdocs Limited - DOX

    $DOX

    Pomerantz LLP is investigating claims on behalf of investors of Amdocs Limited ("Amdocs" or the "Company") (NASDAQ: DOX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

  6. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Banco Santander, S.A. - SAN

    $SAN

    Pomerantz LLP is investigating claims on behalf of investors of Banco Santander, S.A. ("Santander" or the "Company") (NYSE: SAN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

  7. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in O-I Glass, Inc. of Class Action Lawsuit and Upcoming Deadlines - OI

    $OI

    Pomerantz LLP reminds investors with losses on their investment in O-I Glass, Inc. ("O-I Glass" or the "Company") (NYSE: OI) that a class action lawsuit has been filed against the Company. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  8. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Everest Group, Ltd. of Class Action Lawsuit and Upcoming Deadlines - EG

    $EG

    Pomerantz LLP reminds investors with losses on their investment in Everest Group, Ltd. ("Everest" or the "Company") (NYSE: EG) that a class action lawsuit has been filed against the Company.  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  9. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Yiren Digital Ltd. of Class Action Lawsuit and Upcoming Deadlines - YRD

    $YRD

    Pomerantz LLP reminds investors with losses on their investment in Yiren Digital Ltd. ("Yiren" or the "Company") (NYSE: YRD) that a class action lawsuit has been filed against the Company. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  10. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Skechers U.S.A., Inc. of Class Action Lawsuit and Upcoming Deadlines - SKX

    $SKX

    Pomerantz LLP reminds investors that a class action lawsuit has been filed on behalf of sellers of Skechers U.S.A., Inc. ("Skechers" or the "Company") (NYSE: SKX) Class A common stock from April 24, 2025 through the closing of the take-private acquisition of Skechers (the "Take-Private" or "Merger") by 3G Capital Partners L.P. and its affiliates ("3G Capital") on September 12, 2025, including investors who sold their Class A common stock into the Take-Private.  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  11. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Bank of America Corporation of Class Action Lawsuit and Upcoming Deadlines - BAC

    $BAC

    Pomerantz LLP announces that a class action lawsuit has been filed against Bank of America Corporation ("Bank of America" or the "Company") (NYSE: BAC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  12. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gildan Activewear Inc. of Class Action Lawsuit and Upcoming Deadlines - GIL

    $GIL

    Pomerantz LLP reminds investors with losses on their investment in Gildan Activewear Inc. ("Gildan" or the "Company") (NYSE: GIL) that a class action lawsuit has been filed against the Company. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  13. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Millrose Properties, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRP

    $MRP

    Pomerantz LLP announces that a class action lawsuit has been filed against Millrose Properties, Inc. ("Millrose" or the "Company") (NYSE: MRP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  14. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Compass, Inc. of Class Action Lawsuit and Upcoming Deadlines - COMP

    $COMP

    Pomerantz LLP announces that a class action lawsuit has been filed against Compass, Inc. ("Compass" or the "Company") (NYSE: COMP).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  15. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in The Ensign Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - ENSG

    $ENSG

    Pomerantz LLP announces that a class action lawsuit has been filed against The Ensign Group, Inc. ("Ensign" or the "Company") (NASDAQ: ENSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  16. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Netcapital Inc. of Class Action Lawsuit and Upcoming Deadlines - NCPL

    $NCPL

    Pomerantz LLP announces that a class action lawsuit has been filed against Netcapital Inc. ("Netcapital" or the "Company") (NASDAQ: NCPL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  17. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Webull Corporation of Class Action Lawsuit and Upcoming Deadlines - BULL

    $BULL

    Pomerantz LLP announces that a class action lawsuit has been filed against Webull Corporation ("Webull" or the "Company") (NASDAQ: BULL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  18. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Duolingo, Inc. of Class Action Lawsuit and Upcoming Deadlines - DUOL

    $DUOL

    Pomerantz LLP announces that a class action lawsuit has been filed against Duolingo, Inc. ("Duolingo" or the "Company") (NASDAQ: DUOL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  19. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Coastal Financial Corporation of Class Action Lawsuit and Upcoming Deadlines - CCB

    $CCB

    Pomerantz LLP announces that a class action lawsuit has been filed against Coastal Financial Corporation ("Coastal" or the "Company") (NASDAQ: CCB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  20. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Alphabet Inc. of Class Action Lawsuit and Upcoming Deadlines - GOOG

    $GOOG

    Pomerantz LLP announces that a class action lawsuit has been filed against Alphabet Inc. ("Alphabet" or the "Company") (NASDAQ: GOOG).   Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  21. Phase II Study of Ivonescimab in the Perioperative Setting for Resectable NSCLC Published in Nature Medicine

    Akeso, Inc. (9926.HK) today announced that results from a Phase II clinical study evaluating its first-in-class PD-1/VEGF bispecific antibody ivonescimab in the perioperative treatment of resectable non-small cell lung cancer (NSCLC) have been published in the journal Nature Medicine. This Phase II trial assessed the efficacy and safety of perioperative ivonescimab administered either as monotherapy or in combination with chemotherapy. Patients received neoadjuvant treatment followed by surgical resection and subsequent adjuvant ivonescimab.

  22. GOOGL, GOOG Investors Have Opportunity to Lead Alphabet Inc. Securities Fraud Lawsuit

    $GOOG$GOOGL

    Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alphabet Inc. (NASDAQ: GOOGL, GOOG) between May 19, 2026 and July 16, 2026, inclusive (the "Class Period"), of the important December 1, 2026 lead plaintiff deadline.

  23. Global solidarity delivers major boost to Education Cannot Wait as "Hope Starts Here" campaign approaches its US$600 million goal

    Governments and partners rallied behind the world's most vulnerable children today, announcing US$405.8 million in new pledges to Education Cannot Wait (ECW) at its High-Level Replenishment Conference, hosted by Switzerland in Geneva. Together with US$135.8 million in financial resources already secured through previous multi-year donor commitments, these pledges bring ECW's Hope Starts Here campaign total to US$541.6 million, reaching 90% of its US$600 million target.

  24. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines - AVXL

    $AVXL

    Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  25. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Endava Plc of Class Action Lawsuit and Upcoming Deadlines - DAVA

    $DAVA

    Pomerantz LLP announces that a class action lawsuit has been filed against Endava Plc ("Endava" or the "Company") (NYSE: DAVA).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  26. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Fluence Energy, Inc. of Class Action Lawsuit and Upcoming Deadlines - FLNC

    $FLNC

    Pomerantz LLP announces that a class action lawsuit has been filed against Fluence Energy, Inc. ("Fluence" or the "Company") (NASDAQ: FLNC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  27. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tigo Energy, Inc. of Class Action Lawsuit and Upcoming Deadlines - TYGO

    $TYGO

    Pomerantz LLP announces that a class action lawsuit has been filed against Tigo Energy, Inc. ("Tigo" or the "Company") (NASDAQ: TYGO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  28. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Honeywell Aerospace Inc. of Class Action Lawsuit and Upcoming Deadlines - HONA

    $HONA

    Pomerantz LLP announces that a class action lawsuit has been filed against Honeywell Aerospace Inc. ("Honeywell Aerospace" or the "Company") (NASDAQ: HONA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  29. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDX

    $ARDX

    Pomerantz LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  30. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCS

    $DOCS

    Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  31. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Baidu, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIDU

    $BIDU

    Pomerantz LLP announces that a class action lawsuit has been filed against Baidu, Inc. ("Baidu" or the "Company") (NASDAQ: BIDU). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  32. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in FuelCell Energy, Inc. of Class Action Lawsuit and Upcoming Deadlines - FCEL

    $FCEL

    Pomerantz LLP announces that a class action lawsuit has been filed against FuelCell Energy, Inc. ("FuelCell" or the "Company") (NASDAQ: FCEL).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  33. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lincoln Educational Services Corp. of Class Action Lawsuit and Upcoming Deadlines - LINC

    $LINC

    Pomerantz LLP announces that a class action lawsuit has been filed against Lincoln Educational Services Corp. ("Lincoln Educational" or the "Company") (NASDAQ: LINC).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  34. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Dun & Bradstreet Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - DNB

    $DNB

    Pomerantz LLP announces that a class action lawsuit has been filed against Dun & Bradstreet Holdings, Inc. ("Dun & Bradstreet" or the "Company") (NYSE: DNB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  35. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ryde Group Ltd. of Class Action Lawsuit and Upcoming Deadlines - RYDE

    $RYDE

    Pomerantz LLP announces that a class action lawsuit has been filed against Ryde Group Ltd. ("Ryde" or the "Company") (NYSE: RYDE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

  36. Pomerantz Law Firm Announces the Filing of a Class Action Against lululemon athletica inc. and Certain Officers - LULU

    $LULU

    Pomerantz LLP announces that a class action lawsuit has been filed against lululemon athletica inc. ("Lululemon" or the "Company") (NASDAQ: LULU) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 26-cv-14271, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Lululemon securities between March 18, 2026 and September 3, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

  37. Pomerantz Law Firm Announces the Filing of a Class Action Against Tenax Therapeutics, Inc. and Certain Officers - TENX

    $TENX

    Pomerantz LLP announces that a class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company") (NASDAQ: TENX) and certain officers. The class action, filed in the United States District Court for the Middle District of North Carolina, and docketed under 26-cv-01624, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Tenax securities between November 13, 2023 and August 7, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

  38. Pomerantz Law Firm Announces the Filing of a Class Action Against D-Wave Quantum Inc. and Certain Officers - QBTS

    $QBTS

    Pomerantz LLP announces that a class action lawsuit has been filed against D-Wave Quantum Inc. ("D-Wave" or the "Company") (NASDAQ:QBTS) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 26-cv-12155, is on behalf of a class consisting of all persons and entities other than the above-captioned defendants ("Defendants") that purchased or otherwise acquired D-Wave securities between February 27, 2026 and August 25, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

  39. Pomerantz Law Firm Announces the Filing of a Class Action Against Triller Group Inc. and Certain Officers - ILLR

    $ILLR

    Pomerantz LLP announces that a class action lawsuit has been filed against Triller Group Inc. ("Triller" or the "Company") (NASDAQ: ILLR) and certain officers. The class action, filed in the United States District Court for the Central District of California, and docketed under 26-cv-11989, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Triller securities between October 16, 2024 and December 29, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

  40. Pomerantz Law Firm Announces the Filing of a Class Action Against The Chemours Company and Certain Officers - CC

    $CC

    Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours " or the "Company") (NYSE: CC) and certain officers. The class action, filed in the United States District Court for the District of Delaware, and docketed under 26-cv-01299, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

  41. Pomerantz Law Firm Announces the Filing of a Class Action Against Qfin Holdings, Inc. and Certain Officers - QFIN

    $QFIN

    Pomerantz LLP announces that a class action lawsuit has been filed against Qfin Holdings, Inc. ("Qfin" or the "Company") (NASDAQ: QFIN) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 26-cv-06024, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Qfin securities between March 18, 2026 and August 25, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

  42. Pomerantz Law Firm Announces the Filing of a Class Action Against AppLovin Corporation and Certain Officers - APP

    $APP

    Pomerantz LLP announces that a class action lawsuit has been filed against AppLovin Corporation ("AppLovin" or the "Company") (NASDAQ: APP) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 26-cv-10584, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired AppLovin securities between February 12, 2026 and August 5, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

  43. Pomerantz Law Firm Announces the Filing of a Class Action Against AST SpaceMobile, Inc. and Certain Officers - ASTS

    $ASTS

    (ACCESSWIRE) Pomerantz LLP announces that a class action lawsuit has been filed against AST SpaceMobile, Inc. ("AST" or the "Company") (NASDAQ: ASTS) and certain officers.  The class action, filed in the United States District Court for the Western District of Texas, Midland-Odessa Division, and docketed under 26-cv-00378, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired AST securities between March 4, 2025 and July 15, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

  44. MNTN Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into MNTN, Inc. (MNTN)

    $MNTN

    MNTN, Inc.'s (NYSE: MNTN) third-quarter 2026 results fell short of analyst expectations, with revenue of approximately $80.3 million missing consensus estimates and management lowering its full-year revenue outlook. If you purchased MNTN stock and suffered losses following the Company's November 4, 2026 earnings announcement, you may have legal rights. Investors who lost money are encouraged to submit their loss details now. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

  45. DOCS Deadline: DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit

    $DOCS

    Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.

  46. Johnson & Johnson announces U.S. FDA Approval of RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as First and Only Dual-Targeted Therapy for Advanced Head and Neck Cancer

    $JNJ

    Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval for RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) (subcutaneous injection, 160 mg/2,000 units per mL) as a single agent for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum–based chemotherapy and an anti–PD–(L)1 antibody. The indication does not include patients with oropharyngeal squamous cell carcinoma (OPSCC) that is HPV-associated (i.e., by p16 immunohistochemistry). It is the first approval of a dual-targeted therapy in this setting, simultaneously targeting epidermal growth factor receptor (EGFR)- and mesenchymal-epithelial transition (MET).2-3

  47. Launceston Aquatic Centre unlocks more than AUD $77,000 in annual savings with ABB motor and drive technologies.

    The City of Launceston's Leisure and Aquatic Centre in Tasmania, Australia, continues to demonstrate how upgrading infrastructure with modern motor and drive technologies can deliver significant energy efficiency, operational improvements, and financial benefits.

Source: PR Newswire

Content provided by PR Newswire. Redistribution, resale or sublicensing is not permitted.

    PR Newswire press releases | Signal8